| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination C Lucchinetti, W Brück, J Parisi, B Scheithauer, M Rodriguez, ... Annals of Neurology: Official Journal of the American Neurological …, 2000 | 4268 | 2000 |
| Cortical demyelination and diffuse white matter injury in multiple sclerosis A Kutzelnigg, CF Lucchinetti, C Stadelmann, W Brück, H Rauschka, ... Brain 128 (11), 2705-2712, 2005 | 2134 | 2005 |
| The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases S Krasemann, C Madore, R Cialic, C Baufeld, N Calcagno, R El Fatimy, ... Immunity 47 (3), 566-581. e9, 2017 | 1992 | 2017 |
| The relation between inflammation and neurodegeneration in multiple sclerosis brains JM Frischer, S Bramow, A Dal-Bianco, CF Lucchinetti, H Rauschka, ... Brain 132 (5), 1175-1189, 2009 | 1723 | 2009 |
| The immunopathology of multiple sclerosis: an overview H Lassmann, W Brück, CF Lucchinetti Brain pathology 17 (2), 210-218, 2007 | 1544 | 2007 |
| A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica CF Lucchinetti, RN Mandler, D McGavern, W Bruck, G Gleich, ... Brain 125 (7), 1450-1461, 2002 | 1393 | 2002 |
| Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research R Gold, C Linington, H Lassmann Brain 129 (8), 1953-1971, 2006 | 1324 | 2006 |
| Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? M Kerschensteiner, E Gallmeier, L Behrens, VV Leal, T Misgeld, ... The Journal of experimental medicine 189 (5), 865-870, 1999 | 1303 | 1999 |
| Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase … H Babbe, A Roers, A Waisman, H Lassmann, N Goebels, R Hohlfeld, ... The Journal of experimental medicine 192 (3), 393-404, 2000 | 1253 | 2000 |
| Pathological mechanisms in progressive multiple sclerosis DH Mahad, BD Trapp, H Lassmann The Lancet Neurology 14 (2), 183-193, 2015 | 1250 | 2015 |
| Inflammatory cortical demyelination in early multiple sclerosis CF Lucchinetti, BFG Popescu, RF Bunyan, NM Moll, SF Roemer, ... New England Journal of Medicine 365 (23), 2188-2197, 2011 | 1227 | 2011 |
| Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions B Kornek, MK Storch, R Weissert, E Wallstroem, A Stefferl, T Olsson, ... The American journal of pathology 157 (1), 267-276, 2000 | 1189 | 2000 |
| Progressive multiple sclerosis: pathology and pathogenesis H Lassmann, J Van Horssen, D Mahad Nature Reviews Neurology 8 (11), 647-656, 2012 | 1170 | 2012 |
| Oligodendrocytes: biology and pathology M Bradl, H Lassmann Acta neuropathologica 119, 37-53, 2010 | 1040 | 2010 |
| Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis CF Lucchinetti, W Brück, M Rodriguez, H Lassmann Brain pathology 6 (3), 259-274, 1996 | 1037 | 1996 |
| Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease C Bancher, C Brunner, H Lassmann, H Budka, K Jellinger, G Wiche, ... Brain research 477 (1-2), 90-99, 1989 | 1008 | 1989 |
| Cellular immune reactivity within the CNS H Wekerle, C Linington, H Lassmann, R Meyermann Trends in neurosciences 9, 271-277, 1986 | 991 | 1986 |
| Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy H Lassmann, W Brück, C Lucchinetti Trends in molecular medicine 7 (3), 115-121, 2001 | 958 | 2001 |
| Remyelination is extensive in a subset of multiple sclerosis patients P Patrikios, C Stadelmann, A Kutzelnigg, H Rauschka, M Schmidbauer, ... Brain 129 (12), 3165-3172, 2006 | 950 | 2006 |
| Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. C Linington, M Bradl, H Lassmann, C Brunner, K Vass The American journal of pathology 130 (3), 443, 1988 | 898 | 1988 |
